KPV

At a glance

• SequenceLysine-proline-valine.
• Research areasInflammatory signaling, intestinal models, skin models, and wound-related research.
• Evidence contextMuch of the available evidence is laboratory or animal research. Human dosing and long-term safety are not established.
• Common examplesThe supplied material illustrates 5 mg and 10 mg vials. Confirm the actual vial label before calculating.

Example reconstitution math

The supplied reference pairs 5 mg with 1 mL and 10 mg with 2 mL. Both combinations equal 5 mg/mL, so a 250 mcg quantity occupies 0.05 mL, or 5 units on a U-100 syringe.

Suggested dosing context

The supplied sheet lists a standard range of 200-500 mcg and a maximum range of 250 mcg-1 mg, with two eight-week schedules.

• Uses / benefitsAnti-inflammatory and immune-modulation research; gastrointestinal repair, wound or injury healing, skin-barrier appearance, psoriasis, and eczema are listed on the supplied sheet.
• Reconstitution5 mg with 1 mL BAC water; 10 mg with 2 mL BAC water.
• FrequencyDaily, or five days on followed by two days off.
• TimingMorning or evening based on preference and tolerance.
• CycleEight weeks on followed by four weeks off.
• AdministrationSubcutaneous.
• StorageKeep refrigerated at 2-8 C.
• Vials neededStandard: four 5 mg vials or two 10 mg vials. Maximum: seven 5 mg vials or four 10 mg vials.

Additional supplied notes

• Start low and titrate slowly for a first peptide cycle.
• Do not take if pregnant, breastfeeding, or diagnosed with active cancer.
• The sheet says benefits may build over days to weeks.
• Do not mix KPV in the same vial with other peptides. If combining, draw separately and mix only in the syringe immediately before injection.
• Nausea or fatigue may occur; the sheet says to lower the quantity if this happens.

Calculation examples

Research sources

• KPV signaling in human keratinocyte cells
• Tripeptides in wound healing and skin regeneration